Description: The days of reinsurance treaties bound by a handshake are long gone. Treaties have evolved into complex legal documents. The session will use a recently released study on recapture provisions as a starting point and will expand the discussion to other key treaty provisions. The focus will be on understanding the intentions, concerns and relative positions of both the direct company and the reinsurer so that a mutually beneficial compromise can be explored.

Description: As more gene and cell therapies enter the market at increasingly higher price points, they are ushering in a new era of medicine for rare diseases. Unlike most traditional therapies, gene and cell therapies typically have a short or one-time treatment administration and are anticipated to provide long-term clinical benefits. Actuaries must be prepared to assess, manage, and/or mitigate the risks associated with these therapies. This session includes three different perspectives—a regional plan, a stop loss/reinsurance carrier, and a health care consultant.

Description: As the adoption of offshore reinsurance strategies continues to grow among insurers seeking to optimize their capital and balance sheets, a critical focus for both prospective and current adopters is the establishment or enhancement of existing data, technology, and modeling processes to meet offshore reporting requirements. Drawing from practical experience, this presentation aims to provide attendees with key insights for successfully producing the necessary reporting items for offshore reinsurance entities, along with considerations for operational efficiency, model and data governance, and management decision-making.

Description: This session will provide an overview of the latest developments in life reinsurance, with a particular focus on offshore reinsurance activities. Attendees will gain insights into the key drivers behind these deals, including regulatory and strategic considerations. The discussion will delve into the factors influencing jurisdiction selection for offshore reinsurance, with a specific emphasis on Bermuda as a leading jurisdiction. The session will explore Bermuda's regulatory regime, its advantages for reinsurance transactions, and how it aligns with global regulatory standards. Additionally, the session will discuss NAIC's recent developments regarding offshore reinsurance AAT and its implications for insurers and reinsurers operating in this space.